- Inactivated Vaccines
- Recombinant vaccines
- Live attenuated vaccines
- DNA vaccines
- Subunit vaccines
Europe Swine Vaccines Market report gives a comprehensive outlook across the globe with special emphasis on key countries such as United Kingdom, Spain, Italy, Germany and the Rest of Europe. The report gives historical, current, and future market sizes (US$ Mn) on the basis of vaccine type, disease type, distribution channel and region. This report studies Europe Vaccines Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged.
Vaccines are the biological preparations that provide acquired immunity to the particular disease. Vaccine typically contains the agent that resembles a disease-causing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy. In September 2015, Boehringer Ingelheim Animal Health launched ingelvac PRRSFLEX EU for piglets and ReproCyc PRRS EU for sows for control of reproductive and respiratory syndrome.
Fastest Growing Market
Europe Swine Vaccines Market drivers are High demand for healthy pork meat and rise in pork meat production industries, Rise in R&D expenditure for the innovation of newer vaccines and launching of vaccines into the market and Rise in prevalence of various infectious diseases. Restraints are Stringent regulatory policies for the swine vaccine approval, Adverse effects such as allergies associated with the vaccines and High cost of vaccines.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.